Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

NMTC stock hub

NeuroOne Medical Technologies Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NMTCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

40.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NMTC

In the news

Latest news · NMTC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-146.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-96.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NMTC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

198

Groups with data

Currency

USD

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001500198
Company name	NeuroOne Medical Technologies Corporation
Country	United States
Country code	US
Cusip	64130M308
Employees	18
Employees Change	1%
Employees Change Percent	5.88
Enterprise value	$36.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	US64130M3088
Last refreshed	2026-05-10
Market cap	$40.2M
Market cap category	Nano-Cap
Price	$4.76
Price currency	USD
Rev Per Employee	650,897.78x
Sector	Healthcare
Sic	3841
Symbol	NMTC
Website	https://nmtc1.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.98%
EV Sales Forward	2.92x
EV/Sales	3.15x
FCF yield	-15.56%
P/B ratio	6.25x
P/S ratio	3.43x
PS Forward	3.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-65.25%
EBITDA Margin	-63.01%
Gross margin	22.03%
Gross Profit	$2.6M
Gross Profit Growth Q	-76.39%
Net Income	$-6.8M
Net Income Growth Years	1%
Pretax Margin	-58.28%
Profit Margin	-58.28%
Profit Per Employee	$-379,366
ROA	-63.4
Roa5y	-75.09
ROCE	-104.5
ROE	-146.3
Roe5y	-188.8
ROIC	-96.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	21.58%
Cagr3y	-17.44%
Cagr5y	-34.84%
EPS Growth Years	2
Revenue Growth	103.78x
Revenue Growth Q	-11.65x
Revenue Growth Years	4x
Revenue Growth3 Y	47.52x
Revenue Growth5 Y	42.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.55
Assets	$8.6M
Cash	$3.6M
Current Assets	$8.1M
Current Liabilities	$1.3M
Debt	$237,377
Debt Equity	$0.04
Equity	$6.4M
Liabilities	$2.2M
Long Term Assets	$510,525
Long Term Liabilities	$917,233
Net Cash	$3.3M
Net Cash By Market Cap	$8.27
Net Cash Growth	319.28%
Net Debt Equity	$-0.52
Tangible Book Value	$6.4M
Tangible Book Value Per Share	$0.76
WACC	7.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.41
Inventory Turnover	5.08
Net Working Capital	$3.4M
Quick ratio	4.95
Working Capital	$6.8M
Working Capital Turnover	$2.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-58.14%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	21.57%
200-day SMA	4.75
3Y total return	-43.74%
50-day SMA	4.62
50-day SMA vs 200-day SMA	50under200
5Y total return	-88.25%
All Time High	180
All Time High Change	-97.36%
All Time High Date	2018-08-21
All Time Low	2.37
All Time Low Change	100.67%
All Time Low Date	2025-04-09
ATR	0.34
Beta	0.58
Beta1y	0.89
Beta2y	1.46
Ch YTD	4.66
High	4.87
High52	6.96
High52 Date	2025-10-07
High52ch	-31.61%
Low	4.41
Low52	3.27
Low52 Date	2025-12-11
Low52ch	45.39%
Ma50ch	3.07%
Price vs 200-day SMA	0.27%
RSI	53.66
RSI Monthly	45.65
RSI Weekly	51.12
Sharpe ratio	0.58x
Sortino ratio	0.97
Total Return	-58.14%
Tr YTD	4.66
Tr1m	-4.38%
Tr1w	9.43%
Tr3m	1.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.23
Earnings Revenue Estimate	2,576,330x
Earnings Revenue Estimate Growth	85.81x
Operating Income	$-7.6M
Operating margin	-65.25
Price target	$13.5
Price Target Change	$184

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,668,602%
Float Percent	90.77%
Shares Insiders	9.23%
Shares Institutions	37.68%
Shares Out	8,448,837
Shares Qo Q	0.54%
Shares Yo Y	58.14%
Short Float	1.79%
Short Ratio	0.7
Short Shares	1.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7.5M
Average Volume	52,505.15x
Bv Per Share	0.76
CAPEX	$-98,080
Ch1m	-4.38
Ch1w	9.43
Ch1y	21.55
Ch3m	1.67
Ch3y	-43.74
Ch5y	-88.25
Ch6m	14.26
Change	4.85%
Change From Open	4.16
Close	4.54
Days Gap	0.66
Depreciation Amortization	262,075
Dollar Volume	164,519.9
Earnings Date	2026-05-12
Earnings Time	bmo
EBIT	$-7.6M
EBITDA	$-7.4M
EPS	$-0.93
F Score	4
FCF	$-6.3M
FCF EV Yield	-16.97x
FCF Per Share	$-0.74
Financing CF	8,686,502
Fiscal Year End	September
Founded	2,009
Investing CF	-98,080
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-17
Last Report Date	2025-12-31
Last Split Date	2026-04-16
Last Split Type	Reverse
Last10k Filing Date	2025-12-17
Ma150	4.66
Ma150ch	2.08%
Ma20	4.65
Ma20ch	2.34%
Net CF	2,427,266
Next Earnings Date	2026-05-22
Open	4.57
Optionable	Yes
Position In Range	76.69
Post Close	4.76
Postmarket Change Percent	-1.89
Postmarket Price	$4.67
Ppne	471,157
Price Date	2026-05-08
Ptbv Ratio	6.32
Relative Volume	0.66x
Revenue	11,716,160x
SBC By Revenue	10.96x
Share Based Comp	1,284,639
Tr6m	14.26%
Us State	Minnesota
Volume	34,563
Z Score	-3.93

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NMTC pay a dividend?

Capital-return profile for this ticker.

Performance

NMTC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NMTC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+37.7%

Float: +90.8% of shares outstanding

Insider ownership

+9.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NMTC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.7

Neutral momentum band

Price vs 200-day MA

+0.3%

50/200-day relationship not available

Beta (5Y)

0.58

Less volatile than the market

Sharpe ratio

0.58

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NMTC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NMTC stock rating?

NeuroOne Medical Technologies Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NMTC analysis?

The full report lives at /stocks/NMTC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NMTC?

The latest report frames NMTC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NMTC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.